AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Total Liabilities
Everything the company owes to creditors and other parties.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Total Liabilities · Q3 FY2025 · quarter ended Sep 2025
Total liabilities of €18.7M in Q3 FY2025
Q3 FY2025 total liabilities was €18.7M.
Context
- Total liabilities amounted to 11.3% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Total liabilities amounts to 11.3% of total assets for AGMB, versus a peer median of 23.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $316.94M USD | -18.3% | -2.1% | 96.1% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $108.46M USD | -13.6% | -28.6% | 19.3% |
| Mar 2026 | $55.07M USD | +1.9% | +0.2% | 27.7% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €18.7M EUR | — | — | 11.3% |
| Mar 2026 | $3.6M USD | -41.5% | -58.6% | 5.7% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | -16.0% | -15.3% | 23.5% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.